PreCision Dermatology

Cumberland, United States Founded: 2010 • Age: 16 yrs Acquired By Bausch Health
Dermatology products are developed, manufactured, and marketed by PreCision Dermatology.

About PreCision Dermatology

PreCision Dermatology is a Healthcare company based in Cumberland (United States) founded in 2010, and was acquired by Bausch Health in February 2014. Dermatology products are developed, manufactured, and marketed by PreCision Dermatology. PreCision Dermatology has raised $74 million across 3 funding rounds from investors including Golub Capital, Bausch Health and Frazier Healthcare Partners. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.

Company details

PreCision Dermatology was founded in 2010 and operates as a subsidiary of Valeant Pharmaceuticals in Cumberland, United States. Dermatology products are developed, manufactured, and marketed by the company, focusing on pharmaceutical treatments for conditions such as acne, seborrheic dermatitis, atopic dermatitis, dermatoses, and rosacea. Items like Locoid and Clindagel are offered to support skin barrier restoration and related therapies within the pharmaceutical sector.

Key Metrics
  • Total Equity Funding
    $74M (USD)

    in 3 rounds

  • Latest Funding Round
    $67M (USD), Debt – Venture

    Sep 2013

  • Investors
  • Acquired by
    Bausch Health

    (Feb 2014)

Funding Insights of PreCision Dermatology

PreCision Dermatology has successfully raised a total of $74M across 3 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $67 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $74M
  • Total Rounds 3
  • Last Round Debt – Venture β€” $67M
  • First Round $19M

    (Nov 2010)

  • Investors Count 7

All 3 funding rounds of PreCision Dermatology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2013$67MDebt – Venture––
Nov 2012$55MSeries B––
–
Nov 2010$19MSeries A––
–
Valuation history

8 investors in total: 8 institutional.

Investors in PreCision Dermatology

PreCision Dermatology has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Golub Capital, Bausch Health and Frazier Healthcare Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare sector private equity investments are managed by the firm.
1991frazierhealthcare.comSeattle, United States
Private equity firm focused on life science sector
longitudecapital.comMenlo Park, United States
PE firm focused on life science and healthcare companies
novaquest.comRaleigh, United States
US-focused private equity and venture capital investments are managed.
bostonmillenniapartners.comBoston, United States
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
ewhealthcare.comNew York, United States
quakerpartners.com
Private debt investments are managed for U.S. middle market companies.
1994golubcapital.comChicago, United States
Therapeutics for multiple diseases including dermatology and neurology are developed.
1960bauschhealth.comLaval, Canada
Premium access

Investor details for PreCision Dermatology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of PreCision Dermatology

4 dated milestones of PreCision Dermatology across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded PreCision Dermatology is founded.
  2. Funding First funding round of $19.0M.
  3. Funding Latest funding round, Debt – Venture, of $67.0M.
  4. Exit Acquired by Bausch Health.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as PreCision Dermatology (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PreCision Dermatology

PreCision Dermatology was founded in 2010.

PreCision Dermatology is headquartered in Cumberland, United States.

PreCision Dermatology is a funded company, having raised a total of $74M across 3 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Nov 2010.

PreCision Dermatology was founded in 2010 and operates as a subsidiary of Valeant Pharmaceuticals in Cumberland, United States. Dermatology products are developed, manufactured, and marketed by the company, focusing on pharmaceutical treatments for conditions such as acne, seborrheic dermatitis, atopic dermatitis, dermatoses, and rosacea. Items like Locoid and Clindagel are offered to support skin barrier restoration and related therapies within the pharmaceutical sector.

PreCision Dermatology has 8 investors. Key investors include Golub Capital, Bausch Health, Frazier Healthcare Partners, Longitude Capital, and NovaQuest Capital Management.

Yes. PreCision Dermatology was acquired by Bausch Health in February 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available